Publications by authors named "Vera Pierre"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

66

Total Likes

29

Extended Reach

18,099

Social Features

16
F
From Nuclear Medicine Specialist to Cancer Center Director: Jeremie Calais Talks with Pierre Vera about Leading Through Change in Nuclear Medicine.
Pierre Vera, Jeremie Calais

J Nucl Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the collapsed-cone superposition for whole-body patient-specific dosimetry in [177Lu]Lu-PSMA-617 radionuclide therapy.
Aya Terro, Solène Perret, Arthur Dumouchel, David Tonnelet, Agathe Edet-Sanson, Pierre Vera, Pierre Decazes

Med Phys· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-modal MRI synthesis with conditional latent diffusion models for data augmentation in tumor segmentation.
Aghiles Kebaili, Jérôme Lapuyade-Lahorgue, Pierre Vera, Su Ruan

Comput Med Imaging Graph· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer.
Pierre Vera, Philippe Giraud, Sébastien Hapdey, Pierrick Gouel, Orianne Jan, Pierre Boisselier

J Nucl Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards fully automatized [177Lu]Lu-PSMA personalized dosimetry based on 360° CZT whole-body SPECT/CT: a proof-of-concept.
Arnaud Dieudonné, Aya Terro, Arthur Dumouchel, Solène Perret, Agathe Edet-Sanson, Pierre Vera, Pierre Decazes

EJNMMI Phys· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial.
Sophie Leboulleux, Claire Bournaud, Cecile N Chougnet, Livia Lamartina, Slimane Zerdoud, Pierre Vera

Lancet Diabetes Endocrinol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F]FDG-PET-guided radiotherapy for stage III non-small-cell lung cancer - Authors' reply.
Sébastien Thureau, Philippe Giraud, Gérard Zalcman, Pierre Vera

Lancet Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trial.
Pierre Vera, Sébastien Thureau, Florence Le Tinier, Philippe Chaumet-Riffaud, Sébastien Hapdey, Pierre Boissellier

Lancet Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An unusual case of primary splenic soft part alveolar sarcoma: case report and review of the literature with emphasis on the spectrum of TFE3-associated neoplasms.
René Guérin, Anne-Lise Menard, Emilie Angot, Nicolas Piton, Pierre Vera, Pierre-Alain Thiébaut

Diagn Pathol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosimetry for targeted radionuclide therapy in routine clinical practice: experts advice vs. clinical evidence.
Arnaud Dieudonné, Clément Bailly, Florent Cachin, Agathe Edet-Sanson, Françoise Kraeber-Bodéré, Pierre-Yves Salaun, Pierre Vera

Eur J Nucl Med Mol Imaging· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient brain tumor segmentation using Swin transformer and enhanced local self-attention.
Fethi Ghazouani, Pierre Vera, Su Ruan

Int J Comput Assist Radiol Surg· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological efficacy of simulated radiolabeled Lipiodol® ultra-fluid and microspheres for various beta emitters: study based on VX2 tumors.
Arnaud Dieudonné, Stéphanie Becker, Miguel Soares, Claire Hollenbeck, Marie-Christine De Goltstein, Pierre Vera

EJNMMI Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer.
Pierre Decazes, Samy Ammari, Younes Belkouchi, Léo Mottay, Littisha Lawrance, Pierre Vera

J Immunother Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial.
Dana Hartl, Yann Godbert, Xavier Carrat, Stéphane Bardet, Audrey Lasne-Cardon, Pierre Vera

Trials· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the capability and reproducibility of RECIST 1.1. measurements by technologists in breast cancer follow-up: a pilot study.
Pierrick Gouel, Françoise Callonnec, Émilie Levêque, Céline Valet, Axelle Blôt, Pierre Vera

Sci Rep· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trial.
Dana Hartl, Yann Godbert, Xavier Carrat, Stéphane Bardet, Audrey Lasne-Cardon, Pierre Vera

Trials· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx Cancers.
Pierrick Gouel, Françoise Callonnec, Franchel-Raïs Obongo-Anga, Pierre Bohn, Emilie Lévêque, Pierre Vera

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of the HECKTOR Challenge at MICCAI 2022: Automatic Head and Neck Tumor Segmentation and Outcome Prediction in PET/CT.
Vincent Andrearczyk, Valentin Oreiller, Moamen Abobakr, Azadeh Akhavanallaf, Panagiotis Balermpas, Pierre Decazes, Pierre Vera

Head Neck Tumor Chall (2022)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in PET and MRI imaging of tumor hypoxia.
Pierrick Gouel, Pierre Decazes, Pierre Vera, Isabelle Gardin, Sébastien Thureau, Pierre Bohn

Front Med (Lausanne)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs.
Pierre Decazes, Samy Ammari, Antoine De Prévia, Léo Mottay, Littisha Lawrance, Pierre Vera

Diagnostics (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-task multi-scale learning for outcome prediction in 3D PET images.
Amine Amyar, Romain Modzelewski, Pierre Vera, Vincent Morard, Su Ruan

Comput Biol Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using 18F-FDG-PET/CT Metrics to Predict Survival in Ra-Dio-Iodine Refractory Thyroid Cancers.
Malanie Roy, Agathe Edet-Sanson, Hervé Lefebvre, Pierre Vera, Pierre Decazes

Diagnostics (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UMI-Varcal: A Low-Frequency Variant Caller for UMI-Tagged Paired-End Sequencing Data.
Vincent Sater, Pierre-Julien Viailly, Thierry Lecroq, Élise Prieur-Gaston, Élodie Bohers, Pierre Vera

Methods Mol Biol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Brochet et al. A Quantitative Comparison between Shannon and Tsallis-Havrda-Charvat Entropies Applied to Cancer Outcome Prediction. 2022, , 436.
Thibaud Brochet, Jérôme Lapuyade-Lahorgue, Alexandre Huat, Sébastien Thureau, David Pasquier, Pierre Vera

Entropy (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis